Ardian signed an agreement to acquire approximately 60% of Dedalus Holding from Mandarin Capital Partners, Hutton Collins Partners, and Health Holding Company. The founder reinvested to retain a 40% stake and continued to lead the group as CEO and Chairman to ensure management continuity. The transaction was strategically timed following Dedalus's acquisition of a majority stake in NoemaLife, a listed competitor. The partnership with Ardian is designed to provide the financial resources and international network necessary to drive a large-scale consolidation process in the European healthcare IT market. The strategic focus under Ardian's ownership centers on scaling the business across 25 countries, increasing R&D investments for clinical innovation, and optimizing service delivery models.

This transaction is part of the TMT (Tech, Media, Telecom) industry, which currently tracks an average EBITDA multiple of 13.6x since the beginning of 2026, 3.2% decrease compared to 2025. This data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.